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THAT the liver is the normal source of serum perchloric acid soluble al-globulin
has now been reasonably well established (Hochwald, Thorbecke and Asofsky,
1961; Sarcione, 1962, 1963; Richmond, 1963; Robinson, Molnar and Winzler,
1964). Working on the hypothesis that if in cancer the liver is stimulated to
produce more xl-globulin then the organ itself might contain more of these pro-
teins, it was shown that in human cancer there was a higherlevel ofHC104 soluble
cxl-globulin in the liver than in non-cancer liver (Burston, Tombs, Apsey and
Maclagan, 1963). The a1-globulin extracted was identified as the 3-5 S a1 glyco-
protein with rather surprisingly only a trace of orosomucoid, the more abundant
serum HCIO4 soluble ac-globulin. Apart from the cl-globulin component, human
liver HC104 extracts also contained a number of basic proteins, one of which,
designated component A, tended to decrease in cancer. The above changes in the
liver perchloric acid soluble proteins were found whether the tumour was present
in the liver or not, and suggested that the liver was being influenced by a humoral
mechanism.
The study of autopsy material leaves a lot to be desired both from the point
of view of freshness ofmaterial and because the tissue is obtained at the terminal
stages of the disease so that other non-specific effects may be involved. To
overcome these difficulties the above work was extended to the tumour-bearing rat
and an attempt was made to confirm our previous findings under more controlled
experimental conditions.
The Walker 256 carcinoma was chosen for this work as it could be made to
growsubcutaneously as adiscrete, encapsulated tumour andunderthese conditions
did not metastasise to the liver. This tumour is also known to produce changes
in the serum al-globulin level similar to those found in human cancer (Darcy,
1957; Weimer, Quinn, Redlich-Moshin and Nishihara, 1957). A preliminary
account ofour work has been published previously (Burston et al., 1963; Burston,
Apsey, Tombs and Maclagan, 1963).
METHODS AND MATERIALS
Animals
Albino, male Wistar rats (average weight 180 g.) were obtained from A. Tuck &
Son Ltd., Rayleigh, Essex. The animals were maintained on Oxo diet 41B and
tap water ad libitum.PERCHLORIC ACID SOLUBLE PROTEINS
Walker tumour transplantation
Apparently viable tumour tissue obtained from a donor bearing a 7-day-old
tumour was implanted subcutaneously at the mid-line of the back by trochar
under light ether anaesthesia. Control animals were subjected to sham implanta-
tion.
Rat liver extracts and perchloric acid solublefraction
These were prepared as described previously (Burston, Tombs et al., 19(3).
Protein Estimation Methods
Liver supernatant protein
A volume (2 ml.) ofthe microsome-free sucrose supernatant was diluted to 4 ml.
with distilled water and two 1 ml. aliquots were taken. To these 0.5 ml. 5%0 w/v
phosphotungstic acid in 2 N HC1 was added and the mixture was allowed to stand
for 10 minutes. After centrifuging at 3,000 g for 10 minutes the supernatant was
discarded and 4 ml. ofbiuret reagent (6 g. sodium potassium tartrate, 1-5 g. copper
sulphate, 11 2 g. sodium hydroxide/litre) was added to the precipitate which was
dissolved with stirring. After standing for 30 minutes the extinction at 540 m,u
was measured in 1 cm. cuvettes. Crystalline bovine albumin was used to construct
a standard calibration curve as the colour produced was not directly proportional
to protein concentration.
Total serutm protein
Two 0 1 ml. portions of serum were diluted to 1 ml. with distilled water, 4 ml.
biuret reagent was added and protein concentration was determined as above.
Correction for haemoglobin contamination was made by the method of King and
Wootton (1956).
Liver perchloric acid soluble protein
This was determined by the method of Lowry, Rosebrough, Farr and Randall
(1951).
Serum glycoprotein
A volume (0.1 ml.) of serum previously diluted 0 5 ml. to 1-5 ml. was diluted to
1 ml. with water and 0-5 ml. of 1-8 N HC104 was added. After standing for 10
minutes the precipitate was sedimented at 7,000 g for 5 minutes and discarded.
To 1 ml. of the supernatant 0-2 ml. of 5 0/ phosphotungstic acid in 2 N HCl was
added and the mixture was again allowed to stand for 10 minutes. After centri-
fugation at 3000 g for 10 minutes the precipitate was treated with 2 ml. of Lowry
reagent C and the protein estimated as above.
Electrophoresis
Immuno-diffusion, immuno- and cellulose acetate electrophoresis
These were carried out as described previously (Tombs, Cooke, Burston and
Maclagen, 1961; Burston, Tombs, Apsey and Maclagan, 1963).
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Anti-sera
Rabbit anti-rat serum was obtained from Burroughs Wellcome Ltd. Specific
anti-sera to isolated liver perchloric acid soluble fractions were prepared in rabbits
using 30 mg. of antigen protein in 10 ml. of Freund's incomplete adjuvant and
10 ml. sterile saline. The mixture was homogenised and 5 ml. injected intra-
peritoneally, 0.6 ml. intravenously and 4 ml. at various intramuscular sites. The
animal was bled after 4 weeks and a booster dose of2 ml. ofthe above mixture was
given after 6 weeks.
Carbohydrate determinations
Both qualitative and quantitative carbohydrate determinations were carried
out as described previously (Burston, Tombs et at., 1963) except that paper chroma-
tography was replaced bythinlayer chromatography onglassplates 15 cm. x 7cm.
coated with MN-cellulose powder 300 G. (Macherey, Nagel and Co., Duiiren,
Germany).
Cellulose Ion Exchange Chromatography
DEAE-cellulose Chromatography
DEAE-cellulose was prepared according to the methods of Peterson and Sober
(1956). Chromatography was carried out at room temperature on a column
5 x4cm.
The ammonium sulphate precipitate from the perchloric acid extract of 1400 g.
rat liver was dialysed against 0.01 M disodium hydrogen phosphate (3-58 g./litre
pH 8.6) and applied to the column directly. The unbound fraction was collected
in bulk before elution of the bound protein with the gradient system previously
described for the fractionation of serum protein (Tombs et al., 1961). The extinc-
tion ofthe effluent at 280m/, was used as a rough guide to locate the fractions but
because of the great variation in specific extinction of these proteins it could not
be used for quantitative estimation. The contents (6 ml.) ofthe tubes comprising
each peak of the chromatogram were pooled, dialysed against distilled water and
freeze dried.
RESULTS
Species variation of liver perchloric acid soluble protein
Although in general rat liver extract was composed ofbasic and acidic proteins
as in the case ofhuman liver, these had a somewhat different distribution. Fig. 1
shows that the electrophoretic pattern of the liver perchloric acid soluble protein
varies in different species, especially with regard to the basic proteins, AR, BR, CR
and DR. This species difference makes it difficult to correlate the rat results with
those ofthe human. Nevertheless, the rat liver extract does contain a component
(FR) ofal-globulin mobility part of which is identical with a serum a1-globulin.
Thisisillustrated in Fig. 2 which shows theresults ofOuchterlony diffusion analysis
of rat serum against an anti-serum raised against a fraction isolated from the per-
chloric acid extract ofrat liver (Fraction 3, Fig. 4). This anti-serum gave a single
precipitin line with rat serum and showed the identity of this serum component
with a component in both liver and serum perchloric acid soluble fractions. Immu-
noelectrophoresis (Fig. 2) ofrat serum against a mixture ofspecific and polyvalen-
202PERCHLORIC ACID SOLUBLE PROTEINS
C
ER
D
FR
E
-ve
203
MAN
+ve
E
RAT
V,
I-
z
I- w
I=
z
I.-
LIJ
u
Ji
GUINEA-PIG
RABBIT
2 0 2
MIGRATION DISTANCE (cm.)
FIG. 1. Scans of cellulose acetate electrophoresis strips of perchloric acid extracts of human and various animal livers. Electrophoresis in veronal buffer pH 8.6.D. BURSTON, M. E. APSEY AND N. F. MACLAGAN
anti-serum indicated that the component precipitated by the specific anti-serum
had a,-globulin mobility and it has been arbitrarily called oclA-globulin. The
polyvalent anti-rat serum was used to show the position of albumin.
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FiG. 2.-Above: Ouchterlony diffusion analysis of (A) rat serum perchloric acid extract;
(B) rat liver perchloric acid extract; (C) whole rat serum. Below: Immunoelectropho-
resis, in veronal buffer pH 8-6, of rat serum diluted 1: 10 with saline.
Anti-serum 1 = Burroughs Wellcome rabbit anti-rat/mouse serum. Anti-serum 2 =
Rabbit anti-rat liver a,-globulin (Fraction 3 Fig. 4). Anti-serum 1 + 2 = 1: 1 mixture
of above.
Effect of tumour growth on the rat proteins
The mean values for various parameters at different stages of tumour growth
are shown in Table I. This shows that tumour growth can be divided into two
parts, firstly a slow growth phase over the first 6 days in which the tumour had
little effect on any of the parameters measured with the exception of the serum
glycoprotein, followed by a rapid growth phase in which more obvious changes
occurred. During the rapid growth phase the increase in total body weight of the
tumour-bearing rat appeared to keep pace with that of the control but when the
tumour weight was subtracted it was evident that the tumour was growing at the
expense of the body. There was an increase in liver weight, maximal 13 days
after transplantation, which was significant when the weight of the organ was
expressed as a percentage of the total body weight. The concentration of total
liver soluble protein was not affected. Histological examination showed that
the enlarged livers had a normal lobular architecture but were characterised by
non-specific, periportal, round cell infiltartion.
The total serum protein concentration decreased over the period of rapid
tumour growth but did not alter subsequently even at large tumour size. The
serum glycoproteins on the other hand increased dramatically during the rapid
growth phase, reached a maximum at 13 days and then declined. No significant
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TABLE I.-Effect of Tumour Growth on Rat Body and Liver Weight,
Liver and Serum Proteins (Mean : S.E. where appropriate)
Days after transplantation
No. animals
Mean total body wt. g.
Mean tumour wt. g.
Mean body wt.-tumour wt.
g.
Control
Exp.
Control
Exp.
Mean liver wt. g. . Control
Exp.
Liver wt. % total body wt. . Control
Exp.
Total liver soluble protein g./ Control
100 g. wet wt. . . Exp.
Total liver perchloric acid Control
soluble protein mg./100 g. Exp.
wet wt.
Total serum protein Control
g./100 ml. . . Exp.
Serum glycoprotein Control
mg./100 ml. . . Exp.
Significant resu
0
6
164
6
6
5
216
207
3 0
204
7 0
4*3±0- 1
6-0±0-3
9 3±2-7
9*2
8-3
4-3±0*1
4-1±0-1
7*6±0-9
8-0±0 7
22-9±4 2
21 0±6 5
13
6
5
240
229
26.0
203
10-4
11.9
4-3±0+ 2
52±0 3*
6*8±0-9
6 6i±00 5
28 1±7-1
35-2±6+ 9
21
6
5
249
267
44 0
223
10-2
12 3
4-1±i0 1
4 6±0 2*
6 1±0+ 8
5 6±0 3
11- 1+3O 0
24 2±6- 8
6-6±0-2 6 3±0-3 6-4±0-2 5-9±0 1
5-7±0-4 5-2±0-3* 5 3±0 3
107±5- 1 169*5±6- 1 196-2±10 7 199 8±10-9
- 263-7±24 7t 885-6±158 4t 521.8±124-4*
ultsshownthus p*<0 05 tp<0.01.
increase was found in the total liver perchloric acid soluble protein, although the
values were above normal at 13 and 21 days.
Table II shows an electrophoretic analysis of the HCl04 soluble liver protein
in two experiments 12-13 days after tumour implantations. In one of these
experiments the total perchloric acid soluble protein was significantly increased
TABLE II.-Electrophoretic Components ofLiver Perchloric Acid Soluble
Fraction in Tumour-bearing Rats (Mean ± S.E.)
LIVER
r- .A
I
(1) Controls
No. rats . . . 6
Age of tumour days
Mean wt. of tumour g.
Total HC1O sol. prot. mg.l00 g. 28 1±7 1
wet wt.
Exp.
5
13
26
35-2±6-9
(2) Controls
6
31*3±5 3
Exp.
6
12
40
48-0±4-4*
Tumour
5
12
21
20* 1±5 9
Electrophoretic fraction8
(mg./100 g. wet weight)
AR-ve . . . 0-6±03 1*3±0-6 0 3±0 7 3.8±1-0t
BR. . . . 10-7±2-8 13-0±2 2 9-3±1 7 14-0±1-4
CR + DR 4 * . 4-9±L2 8-9±2-2 6-8±1-1 12-7±0.9t
ER. * . . 3 4±0-9 5-3±1-4 5-4±1 3 10.0+1.5*
FR (al) . . 44±1-3 4-8±0-8 4-6±0-8 56±0-6
GR . . . 2-3±0 6 1 1±0 1 2-5±0-3 1 0±0 3t
HR+ve . . . 8±0-5 1 0±0 1 2-4±0-3 0 9±0 3t
Significant results shown thus: *p<005 tp<0-01
For definition of fractions see Fig. 1.
r-
-A-
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due mainly to anincrease in the basic components (AR, BR, CR + DR). No increase
was seen in the al-globulin fraction (FR).
Table II also shows the level of perchloric acid soluble protein in the tumour,
which is lower than that in the liver. This finding does not suggest the tumour as
the source of the increased serum glycoprotein.
The electrophoretic analysis of the liver extracts revealed a decrease in
components GR and HR, two acidic components ofmobility greater than albumin.
These components differed from the corresponding acidic components in human
liver in that they did not stain for acid mucopolysaccharide nor did they produce
any hexose after hydrolysis and thin layer chromatography.
When the levels ofGR and HR were determined in tumours ofdifferent weight
but similar growth period, it was found that the decrease was correlated with
tumour weight (Fig. 3) and indeed in some cases when the tumour weight was
very large these components disappeared completely. This is in contrast with
the total liver HC104 soluble protein which was not correlated with tumour weight
(Table I).
DEAE-cellulose chromatography of rat liver perchloric acid soluble protein
A typical chromatographic fractionation ofHC104 soluble protein from 1400 g.
rat liver is shown in Fig. 4. As with human liver the basic proteins were confined
to the first peak (1) eluted from DEAE-cellulose. The al-globulins were eluted in
two peaks (3 and 4) and electrophoresis indicated that the peak (3) was mainly a
slower migrating component and the peak (4) a faster migrating component. Both
components had an electrophoretic mobility within the range of component (FR)
inwhole liverHC104 extract. Althoughthe separation was not complete, fractions
(3 and 4) were used to prepare anti-sera and for carbohydrate analysis. Both
cl-globulin fractions contained 3 % hexose.
DISCUSSION
The results presented here indicate that the finding of an increased level of
al-globulin in the cancerous human liver does not apply to the tumour-bearing rat,
despite the similar increase in the level ofHC0104 soluble proteins in the serum. The
absence of increased hepatic levels can probably be explained by the finding of
Peters (1962) that serum albumin, although synthesised by the liver, passes from
the site of synthesis into the sinusoids via the endoplasmic reticulum without
becoming soluble in the cytoplasm. If this mechanism is true for al-globulin
synthesis also, then a higher level in the liver cytoplasm would not be expected.
A similar conclusion has been reached by Robinson et al. (1964). The above
mechnism would also explain the absence of orosomucoid in the human liver
extracts. Similar arguments also apply to the possible synthesis of serum protein
by the tumour, so that the low level oftumourglycoproteins may not be a decisive
finding. However, the work ofMiller, Hanavan, Titthasiri and Chowdhury (1964)
indicates that the tumour is not a significant source of serum glycoprotein.
The increase in the level of serum HC104 soluble cl-globulin was greatest over
the rapid growth phase of the tumour reaching a maximum 13 days after trans-
plantation. This would suggest that the liver is influenced by growing tissue
rather than necrotic tissue, for whilst the Walker tumour contains necrotic tissue
at all stages ofgrowth this would be greatest 21 days after transplantation. The
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fiindings ofMacbeth, Bekesi and Tuba (1963) ofa maximal elevation in total serum
protein bound carbohydrate 14 days after Walker tumour implantation tends to
support these results, although they did not measure the serum glycoprotein levels.
The increase in liver and spleen size during tumour growth has been reported
many times previously (Sherman, Morton and Mider, 1950; Yeakel and Tobias,
1951 ; Stewart and Begg, 1953) and an increase both in nitrogen and in water
content has been shown. The mechanism whereby the liver is induced to increase
in size is not known although the work of Kampschmidt, Mayne, Goodwin and
Clabaugh (1960), in which an increase in organ size was produced by injection of
tumour extracts, indicates that it might be a humoral one. The proportionally
greater increase in liver weight found here after 13 days' tumour growth suggests
that the liver is being influenced by the growing tumour tissue. This is supported
by the findings of Sherman et al. (1950) who found a greater increase in liver
nitrogen content in rats bearing tumours 15-30 per cent of the total bodv weight
than in rats bearing larger tumours.
The decrease in the acidic HC104 soluble components GR and HR appears to
be related to the growth of the tumour, the effect being least in animals bearing
slow-growing tumours. Sherman et al. (1950) have shown a rapid fall in the liver
niitrogen level in tumour-bearing animals just prior to death and suggest that the
animal is metabolising liver protein. The fall in the level of GR and HR, takes
place however, much earlier than the lethal phase of tumour growth and at a
time when the other perchloric acid soluble proteins are elevated, so that it is
possible that here also a humoral mechanism is involved.
SUMMARY
(1) Perchloric acid soluble proteins of rat liver cointained oxl-globuliii and in
addition several acidic and basic tissue components.
(2) The level of the liver al-globulin was not altered in the tumour-bearing rat
despite the large increases found in the serum glycoproteins.
(3) The tumour caused an increase in liver weight and in the total liver HC104
soluble protein which was maximal 13 days after implantation.
(4) Electrophoretic analysis revealed that the increase in HC104 soluble liver
proteins was due mainly to an increase in the basic proteins whilst two acidic
components GR and HR were decreased.
(5) Results are discussed inrelation to the mechainism ofglycoprotein svnthesis.
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